Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.7018 | 1 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.2351 | 0.1395 | 0.5 |
Brugia malayi | Hemopexin family protein | 0.2737 | 0.2106 | 0.2947 |
Schistosoma mansoni | hypothetical protein | 0.2737 | 0.2106 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2351 | 0.1395 | 0.1537 |
Onchocerca volvulus | Matrilysin homolog | 0.4281 | 0.4954 | 1 |
Brugia malayi | Matrixin family protein | 0.4667 | 0.5665 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.4281 | 0.4954 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.193 | 0.0619 | 0.2939 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.2351 | 0.1395 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.4281 | 0.4954 | 0.859 |
Onchocerca volvulus | 0.2737 | 0.2106 | 0.3431 | |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.3744 | 0.3962 | 0.5 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.2351 | 0.1395 | 0.5 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.2351 | 0.1395 | 0.1537 |
Loa Loa (eye worm) | matrixin family protein | 0.4667 | 0.5665 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cmax (ADMET) | = 7.4 mg/ml | Maximum concentration in female C57BL/6 mice administered with 300 mg/kg, po | ChEMBL. | 16366608 |
F (ADMET) | = 1 % | Oral bioavailability in female C57BL/6 mice administered with 300 mg/kg, po | ChEMBL. | 16366608 |
MIC50 (functional) | = 0.37 mg/ml | Activity against Mycobacterium tuberculosis in the absence of mouse serum | ChEMBL. | 16366608 |
MIC50 (functional) | = 0.37 mg/ml | Activity against Mycobacterium tuberculosis H37Rv in presence of 10% mouse serum | ChEMBL. | 16366608 |
T1/2 (ADMET) | = 3.5 hr | Half life in female C57BL/6 mice administered with 300 mg/kg, po | ChEMBL. | 16366608 |
Tmax (ADMET) | = 0.5 hr | Tmax in female C57BL/6 mice administered with 300 mg/kg, po | ChEMBL. | 16366608 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.